Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lexicon Pharmaceuticals I...

    NASDAQ: LXRX · Real-Time Price · USD
    0.66
    -0.01 (-1.71%)
    At close: Jun 16, 2025, 3:59 PM
    0.66
    -1.22%
    After-hours: Jun 16, 2025, 07:41 PM EDT

    Lexicon Pharmaceuticals Statistics

    Share Statistics

    Lexicon Pharmaceuticals has 363.18M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 363.18M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 82.34%

    Shares Floating

    n/a
    		 177M

    Failed to Deliver (FTD) Shares

    n/a
    		 8,265

    FTD / Avg. Volume

    n/a
    		 0.06%

    Short Selling Information

    The latest short interest is 38.83M, so 10.69% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 38.83M

    Short % of Shares Out

    n/a
    		 10.69%

    Short % of Float

    n/a
    		 29.88%

    Short Ratio (days to cover)

    n/a
    		 10.18

    Valuation Ratios

    The PE ratio is -1.18 and the forward PE ratio is -2.24. Lexicon Pharmaceuticals's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -1.18

    Forward PE

    n/a
    		 -2.24

    PS Ratio

    n/a
    		 7.6

    Forward PS

    n/a
    		 1.4

    PB Ratio

    n/a
    		 1.62

    P/FCF Ratio

    n/a
    		 -1.31

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Lexicon Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.44, with a Debt / Equity ratio of 0.74.

    Current Ratio

    n/a
    		 5.44

    Quick Ratio

    n/a
    		 5.44

    Debt / Equity

    n/a
    		 0.74

    Debt / EBITDA

    n/a
    		 -0.59

    Debt / FCF

    n/a
    		 -0.6

    Interest Coverage

    n/a
    		 -12.65

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $301,757.28

    Profits Per Employee

    n/a
    		 $-1,945,660.19

    Employee Count

    n/a
    		 103

    Asset Turnover

    n/a
    		 0.1

    Inventory Turnover

    n/a
    		 2.67

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -62.64% in the last 52 weeks. The beta is 1.01, so Lexicon Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.01

    52-Week Price Change

    n/a
    		 -62.64%

    50-Day Moving Average

    n/a
    		 0.62

    200-Day Moving Average

    n/a
    		 0.94

    Relative Strength Index (RSI)

    n/a
    		 51.53

    Average Volume (20 Days)

    n/a
    		 13,491,547

    Income Statement

    In the last 12 months, Lexicon Pharmaceuticals had revenue of 31.08M and earned -200.4M in profits. Earnings per share was -0.63.

    Revenue

    n/a
    		 31.08M

    Gross Profit

    n/a
    		 30.46M

    Operating Income

    n/a
    		 -197.12M

    Net Income

    n/a
    		 -200.4M

    EBITDA

    n/a
    		 -184.29M

    EBIT

    n/a
    		 -184.82M

    Earnings Per Share (EPS)

    n/a
    		 -0.63
    Full Income Statement

    Balance Sheet

    The company has 66.66M in cash and 108.4M in debt, giving a net cash position of -41.74M.

    Cash & Cash Equivalents

    n/a
    		 66.66M

    Total Debt

    n/a
    		 108.4M

    Net Cash

    n/a
    		 -41.74M

    Retained Earnings

    n/a
    		 -1.97B

    Total Assets

    n/a
    		 297.67M

    Working Capital

    n/a
    		 135.11M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -178.78M and capital expenditures -1.03M, giving a free cash flow of -179.81M.

    Operating Cash Flow

    n/a
    		 -178.78M

    Capital Expenditures

    n/a
    		 -1.03M

    Free Cash Flow

    n/a
    		 -179.81M

    FCF Per Share

    n/a
    		 -0.56
    Full Cash Flow Statement

    Margins

    Gross margin is 98.02%, with operating and profit margins of -634.2% and -644.78%.

    Gross Margin

    n/a
    		 98.02%

    Operating Margin

    n/a
    		 -634.2%

    Pretax Margin

    n/a
    		 -644.78%

    Profit Margin

    n/a
    		 -644.78%

    EBITDA Margin

    n/a
    		 -592.93%

    EBIT Margin

    n/a
    		 -634.2%

    FCF Margin

    n/a
    		 -578.52%

    Dividends & Yields

    LXRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LXRX is $4, which is 488.2% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $4

    Price Target Difference

    n/a
    		 488.2%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 21, 2015. It was a backward split with a ratio of 1:7.

    Last Split Date

    n/a
    		 May 21, 2015

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:7

    Scores

    Altman Z-Score

    n/a
    		 -9.72

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist